Shilpa Medicare jumps 9% on USFDA nod for Dimethyl Fumarate that used for multiple sclerosis patientshttps://www.moneycontrol.com/news/business/markets/shilpa-medicare-jumps-9-on-usfda-nod-for-dimethyl-fumarate-that-used-for-multiple-sclerosis-patients-3186971.html#SHILPAMED